Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Cancer Immunol Res. 2014 Jun 17;2(9):890–900. doi: 10.1158/2326-6066.CIR-13-0199-T

Figure 4.

Figure 4

IL-32 prompts cell activation and cancer related pathways. A Venn diagram reveals the numbers of up-regulated (red) and down-regulated (blue) probe sets in IL-32-treated MyLa cells and / or HH cells. Significantly up-regulated canonical pathways (p<0.05) and selected canonical pathways (with p values close to 0.05) in IL-32-treated MyLa cells and / or HH cells are shown with P values.